- Home
- BRBS vs FENC Comparison
BRBS vs FENC Comparison
Compare BRBS & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBS
- FENC
- Stock Information
- Founded
- BRBS 1893
- FENC 1996
- Country
- BRBS United States
- FENC United States
- Employees
- BRBS N/A
- FENC N/A
- Industry
- BRBS Commercial Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRBS Finance
- FENC Health Care
- Exchange
- BRBS Nasdaq
- FENC Nasdaq
- Market Cap
- BRBS 199.3M
- FENC 172.8M
- IPO Year
- BRBS N/A
- FENC 2001
- Fundamental
- Price
- BRBS $3.20
- FENC $6.02
- Analyst Decision
- BRBS
- FENC Strong Buy
- Analyst Count
- BRBS 0
- FENC 2
- Target Price
- BRBS N/A
- FENC $14.00
- AVG Volume (30 Days)
- BRBS 227.0K
- FENC 173.1K
- Earning Date
- BRBS 01-29-2025
- FENC 11-07-2024
- Dividend Yield
- BRBS N/A
- FENC N/A
- EPS Growth
- BRBS N/A
- FENC N/A
- EPS
- BRBS N/A
- FENC N/A
- Revenue
- BRBS $97,608,000.00
- FENC $49,348,000.00
- Revenue This Year
- BRBS N/A
- FENC $97.94
- Revenue Next Year
- BRBS N/A
- FENC $11.50
- P/E Ratio
- BRBS N/A
- FENC N/A
- Revenue Growth
- BRBS N/A
- FENC 278.09
- 52 Week Low
- BRBS $2.33
- FENC $3.96
- 52 Week High
- BRBS $3.99
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- BRBS 37.99
- FENC 58.92
- Support Level
- BRBS $3.39
- FENC $5.84
- Resistance Level
- BRBS $3.58
- FENC $6.17
- Average True Range (ATR)
- BRBS 0.09
- FENC 0.36
- MACD
- BRBS -0.05
- FENC -0.04
- Stochastic Oscillator
- BRBS 0.00
- FENC 46.67
About BRBS Blue Ridge Bankshares Inc.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, credit cards, online banking, telephone banking, mobile banking, and other activities to other businesses, professionals, consumers, nonprofits, and municipalities. Its primary source of revenue is interest income from the lending activities.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.